CN102441125B - Traditional Chinese medicine preparation for treating cerebral apoplexy sequelae - Google Patents
Traditional Chinese medicine preparation for treating cerebral apoplexy sequelae Download PDFInfo
- Publication number
- CN102441125B CN102441125B CN201110390710.6A CN201110390710A CN102441125B CN 102441125 B CN102441125 B CN 102441125B CN 201110390710 A CN201110390710 A CN 201110390710A CN 102441125 B CN102441125 B CN 102441125B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- medicine preparation
- cerebral apoplexy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the field of traditional Chinese medicine preparations, and in particular relates to a traditional Chinese medicine preparation for treating cerebral apoplexy sequelae. The traditional Chinese medicine preparation is prepared from the following raw materials in parts by weight: 10 parts of astragalus root, 3 parts of chuanxiong rhizome, 3 parts of motherwort, 1 part of leech, 2 parts of long-noded pit viper, 3 parts of coix seed, 3 parts of rhizoma gastrodiae and 2 parts of pseudo-ginseng. The traditional Chinese medicine preparation has the functions of benefiting qi, activating blood circulation, removing blood stasis and dredging collaterals, and has the characteristics of exact treatment effect, high effect taking speed, safety, convenience and no toxic side effect when used for treating cerebral apoplexy sequelae.
Description
Technical field
The invention belongs to field of traditional Chinese, particularly a kind of Chinese medicine preparation for the treatment of cerebral apoplexy sequela.
Background technology
Cerebral apoplexy sequela is a class disease of the primary symptoms such as, crooked mouth and tongue not smoothgoing with hemiplegia, stiff tongue speech, belongs to the acute cerebrovascular disease in modern medicine.To be healthy energy lose and support from void, blood stasis due to qi deficiency, numbness resistance venation, muscle arteries and veins the main pathogenesis of primary disease, is often divided into dividing of apoplex involving the channels and collaterals and Hitting Viscera in clinical, and the traditional Chinese medical science is that principle for the treatment of is treated this disease and obtained promising result by dialectical benefiting QI for activating blood circulation, the eliminating blood stasis and smoothing collaterals taked.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of Chinese medicine preparation for the treatment of cerebral apoplexy sequela, the feature that have determined curative effect, instant effect, safe ready, has no side effect.
A kind of Chinese medicine preparation for the treatment of cerebral apoplexy sequela of the present invention, is characterized in that being made by the raw material of Chinese medicine of following parts by weight: 2 parts of 10 parts of the Radixs Astragali, 3 parts of Rhizoma Chuanxiongs, 3 parts of Herba Leonuris, 1 part of Hirudo, 2 parts of Agkistrodons, 3 parts of Semen Coiciss, 3 parts, Rhizoma Gastrodiae and Radix Notoginseng.
The present invention can make acceptable various preparations on Chinese materia medica, preferably capsule.
Preparation method: processing of medical material is qualified, weighing is assorted, rolls altogether for fine powder, and even, crosses 80 order dusting covers, incapsulates, and every capsules weighs 0.65 gram.
Usage and consumption: oral, one time 8, day take three times, within 30 days, be a course for the treatment of.
Drug action mechanism of the present invention is as follows:
The Radix Astragali: tonifying Qi and lifting yang, strengthening superficial resistance to stop perspiration, inducing diuresis to remove edema, promoting pus discharge and tissue regeneration strengthening, be usually used in the card of blood stasis due to qi deficiency clinically.
Rhizoma Chuanxiong: blood-activating and qi-promoting, wind-expelling pain-stopping, the pungent loose temperature of this product is logical, can invigorate blood circulation and can circulation of qi promoting, be the gas medicine in blood; The sea of blood, outer thorough fur, bypass extremity are pushed up, assigned in the up mountain peak of this product.
Herba Leonuri: blood-activating and qi-promoting, inducing diuresis to remove edema.
Hirudo: removing blood stasis, Xiao Disorder, the salty hardship of this product enters blood system, and merit is apt to removing blood stasis, Xiao Disorder.
Agkistrodon: dispelling wind and removing obstruction in the collateral, arresting convulsion relieving convulsion, this product power of dispeling the wind is strong, and the dredge the meridian passage of holding concurrently, therefore be usually used in facial hemiparalysis, hemiplegia etc.
Semen Coicis: promoting diuresis to eliminate damp pathogen, spleen invigorating, eliminating impediment, clearing away heat and discharging pus.This product can win wet again can relaxing muscles and tendons arteries and veins, to relax contraction anxious; In clinical, normal and Radix Astragali compatibility, strengthens invigorating the spleen and benefiting QI first, second prevents from not understanding because excessively causing contracture with the Radix Astragali, and Zhu Danxi has saying of " muscular contracture contracture, tardiness of speaking in infant stringy pulse adding Semen Coicis ".
Rhizoma Gastrodiae: endogenous wind stopping relieving convulsion, suppressing the hyperactive liver and subsiding YANG, dispelling wind and removing obstruction in the collateral.
Radix Notoginseng: removing stasis to stop bleeding, the analgesic therapy of invigorating blood circulation, this product is usually used in various blood stasis syndromes, can invigorate blood circulation and the dissipating blood stasis that can stop blooding, the clinical ischemic cerebrovascular that is usually used in.
Curative effect judgement:
Effective: clinical symptom disappearance, limb function obviously improve, and take care of oneself.
Take a turn for the better: cardinal symptom obviously alleviates, limb activity has made marked progress.Invalid: symptom is without improvement.
Therapeutic outcome: clinical treatment cerebral apoplexy sequela patient 130 examples, take capsule of the present invention, one time 8, day take three times, within 30 days, be a course for the treatment of.Through three effective 95 examples of course of therapy, account for 73%, 20 examples that take a turn for the better, account for 15%, and invalid 15 examples, account for 12%, total effective rate 88%.Shown in treatment, without any side effects to patient, three large routine tests and hepatic and renal function detect no abnormal.
Below enumerate several model cases:
Case 1: patient Xu so-and-so, man, 46 years old, crooked mouth and tongue, hemiplegia, stiff tongue and retardation in speech, the heavy numbness of brothers after apoplexy, give Drug therapy of the present invention after three courses for the treatment of, and symptom disappears substantially, lower limb exercise obviously improves, and life can be taken care of oneself, and follows up a case by regular visits to 1 year symptom and does not increase the weight of.
Case 2: patient Liu so-and-so, man, 50 years old, because of crooked mouth and tongue, hemiplegia, stiff tongue and retardation in speech, examine as cerebral thrombosis, give Drug therapy of the present invention after three courses for the treatment of, symptom disappears substantially, hemiplegia is obviously improved, and life can be taken care of oneself, and follows up a case by regular visits to 1 year symptom and does not increase the weight of.
Case 3: patient king so-and-so, man, 48 years old, at local hospital examine as cerebral apoplexy sequela because of hemiplegia in May, 2005, the symptoms such as many hospitalize hemiplegia, hemianesthesia, crooked mouth and tongue, stiff tongue and retardation in speech are improved not obvious, and December sensation numb limbs and tense tendons increases the weight of, with dizziness headache, with Zhen Wo institute afterwards, give Drug therapy of the present invention after three courses for the treatment of, symptom disappears substantially, and hemiplegia has clear improvement, can adhere to work, follow up a case by regular visits to 2 years symptoms and do not increase the weight of.
The present invention has the following advantages:
(1) the selected Chinese herbal medicine of the present invention all meets Pharmacopoeia of People's Republic of China regulation, and according to compatibility, the present invention has the effect of benefiting QI for activating blood circulation, eliminating blood stasis and smoothing collaterals.
(2) the present invention not only has good therapeutical effect to apoplexy, and can prevent the generation of primary disease.
(3) the present invention is by determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs, prescription rigorous and scientific, the feature that have determined curative effect, instant effect, has no side effect.
The specific embodiment
Below in conjunction with embodiment, the present invention is described further.
Embodiment
Take by weight raw material: 2 parts of 10 parts of the Radixs Astragali, 3 parts of Rhizoma Chuanxiongs, 3 parts of Herba Leonuris, 1 part of Hirudo, 2 parts of Agkistrodons, 3 parts of Semen Coiciss, 3 parts, Rhizoma Gastrodiae and Radix Notoginseng.
Preparation method: processing of medical material is qualified, weighing is assorted, rolls altogether for fine powder, and even, crosses 80 order dusting covers, incapsulates, and every capsules weighs 0.65 gram.
Claims (1)
1. treat a Chinese medicine preparation for cerebral apoplexy sequela, it is characterized in that being made by the raw material of following parts by weight: 2 parts of 10 parts of the Radixs Astragali, 3 parts of Rhizoma Chuanxiongs, 3 parts of Herba Leonuris, 1 part of Hirudo, 2 parts of Agkistrodons, 3 parts of Semen Coiciss, 3 parts, Rhizoma Gastrodiae and Radix Notoginseng; The preparation method of the Chinese medicine preparation of described treatment cerebral apoplexy sequela be processing of medical material is qualified, weigh and to assort, roll altogether for fine powder, and even, cross 80 order dusting covers, incapsulate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110390710.6A CN102441125B (en) | 2011-11-30 | 2011-11-30 | Traditional Chinese medicine preparation for treating cerebral apoplexy sequelae |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110390710.6A CN102441125B (en) | 2011-11-30 | 2011-11-30 | Traditional Chinese medicine preparation for treating cerebral apoplexy sequelae |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102441125A CN102441125A (en) | 2012-05-09 |
| CN102441125B true CN102441125B (en) | 2014-01-15 |
Family
ID=46004385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110390710.6A Active CN102441125B (en) | 2011-11-30 | 2011-11-30 | Traditional Chinese medicine preparation for treating cerebral apoplexy sequelae |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102441125B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104027559A (en) * | 2014-05-28 | 2014-09-10 | 于恒峰 | Traditional Chinese medicine preparation for treating stroke sequela |
| CN105878769A (en) * | 2014-10-08 | 2016-08-24 | 马中杰 | Medicine formula for preventing cerebral infarction and treating stroke sequelae |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1238186A (en) * | 1998-06-10 | 1999-12-15 | 陈松林 | Medicine for curing hemiplegia and its preparing process |
| CN1554393A (en) * | 2003-12-23 | 2004-12-15 | 山东凤凰制药股份有限公司 | Chinese medicine composition for treating cerebral infarction inacute stage and early recovering stage and preparing process |
| CN101912540A (en) * | 2010-08-20 | 2010-12-15 | 张跃平 | Medicament for treating cerebral infarction |
| CN101954031A (en) * | 2010-10-07 | 2011-01-26 | 山东省千佛山医院 | Medicament for treating vascular dementia and preparation method |
| CN101953909A (en) * | 2010-10-07 | 2011-01-26 | 山东省千佛山医院 | Medicament for treating cerebral infarction and preparation method thereof |
-
2011
- 2011-11-30 CN CN201110390710.6A patent/CN102441125B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1238186A (en) * | 1998-06-10 | 1999-12-15 | 陈松林 | Medicine for curing hemiplegia and its preparing process |
| CN1554393A (en) * | 2003-12-23 | 2004-12-15 | 山东凤凰制药股份有限公司 | Chinese medicine composition for treating cerebral infarction inacute stage and early recovering stage and preparing process |
| CN101912540A (en) * | 2010-08-20 | 2010-12-15 | 张跃平 | Medicament for treating cerebral infarction |
| CN101954031A (en) * | 2010-10-07 | 2011-01-26 | 山东省千佛山医院 | Medicament for treating vascular dementia and preparation method |
| CN101953909A (en) * | 2010-10-07 | 2011-01-26 | 山东省千佛山医院 | Medicament for treating cerebral infarction and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102441125A (en) | 2012-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102266398B (en) | Composition for mud moxibustion of rheumatic diseases | |
| CN105031088A (en) | Foot bathing powder for treating rheumatoid arthritis and preparation method thereof | |
| CN102274378B (en) | Brain-strengthening and thrombosis-resisting pills for treating cerebrovascular diseases and preparation method thereof | |
| CN105998432A (en) | Foot bath powder for treating rheumatism and preparation method thereof | |
| CN105031213A (en) | Traditional Chine medicine foot bathing powder for treating arthritis and preparation method thereof | |
| CN105168917A (en) | Traditional Chinese medicine preparation for treating scapulohumeral periarthritis and preparation method of traditional Chinese medicine preparation | |
| CN102274410A (en) | Mud moxibustion composition for treating rheumatic diseases | |
| CN102441125B (en) | Traditional Chinese medicine preparation for treating cerebral apoplexy sequelae | |
| CN103054965B (en) | External analgesic plaster for treating arthralgia and preparation method of external analgesic plaster | |
| CN103638156B (en) | The vasculitic Chinese medicine preparation for the treatment of blood stasis type | |
| CN102872301A (en) | Anti-rheumatism medicinal liquor and using method thereof | |
| CN102670882A (en) | Chinese medicinal preparation for treating facial paralysis through oral administration | |
| CN102475853A (en) | Tan Fu Kang | |
| CN102406801B (en) | Traditional Chinese medicine wine preparation for treating ischialgia | |
| CN101642521B (en) | Medicine for treating cerebral apoplexy hemiplegy sequela | |
| CN104740450A (en) | Traditional Chinese medicine foot bath powder for treating rheumatism and preparation and application method of traditional Chinese medicine foot bath powder | |
| CN102406837A (en) | Traditional Chinese preparation for treating atrophic debilitys | |
| CN103127349B (en) | Medicine for treating traumatic injury | |
| CN103028022B (en) | Traditional Chinese medicine composition for treating arthralgia | |
| CN102895529A (en) | Medicine treating apoplexy | |
| CN103127283A (en) | Medicine for treating pelvic inflammation | |
| CN102406704B (en) | Chinese medicinal preparation for treating ankylosing spondylitis | |
| CN102091190A (en) | Orally taken Chinese patent medicine pill for treating lumbar intervertebral disc herniation | |
| CN103120768A (en) | Medicament for treating vital myocarditis and cardiomyopathy | |
| CN102038928A (en) | Traditional Chinese medicine for treating acute and chronic urticaria and dermatosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: NANTONG KANGWEIER BIOCHEMICAL ENGINEERING CO., LTD Free format text: FORMER OWNER: SONG AIMIN Effective date: 20141124 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 256100 ZIBO, SHANDONG PROVINCE TO: 226500 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20141124 Address after: 226500, Jiangsu, Rugao Province, such as town 99, Wanshou Road Patentee after: NANTONG KANGWEIERC BIOCHEMICAL CO., LTD. Address before: 256100 Yiyuan people's Hospital, Zibo, Shandong, China Patentee before: Song Aimin |